Affimed NV Correlations
| AFMD Stock | USD 6.53 0.41 6.70% |
The current 90-days correlation between Affimed NV and Tcr2 Therapeutics is -0.13 (i.e., Good diversification). The correlation of Affimed NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Affimed NV Correlation With Market
Significant diversification
The correlation between Affimed NV and NYA is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and NYA in the same portfolio, assuming nothing else is changed.
Affimed |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Affimed Stock performing well and Affimed NV Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Affimed NV's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TCRR | 3.16 | 0.37 | 0.10 | (0.22) | 3.26 | 5.77 | 43.60 | |||
| PIRS | 2.39 | (0.42) | 0.00 | (0.33) | 0.00 | 3.68 | 33.39 | |||
| ADCT | 3.91 | (0.34) | 0.00 | (0.21) | 0.00 | 6.90 | 25.91 | |||
| AGEN | 5.84 | 0.68 | 0.09 | 0.18 | 6.66 | 11.96 | 51.34 | |||
| XFOR | 4.23 | 0.43 | 0.08 | (2.41) | 4.50 | 8.06 | 40.83 | |||
| TERN | 4.05 | (0.01) | 0.00 | (0.02) | 0.00 | 7.30 | 23.03 | |||
| DAWN | 3.15 | (0.24) | 0.00 | (0.17) | 0.00 | 6.30 | 21.23 | |||
| PDSB | 3.73 | (0.91) | 0.00 | (0.45) | 0.00 | 6.98 | 21.19 | |||
| INZY | 2.88 | (0.37) | 0.00 | (0.19) | 0.00 | 4.80 | 18.48 | |||
| LPTX | 3.97 | 0.11 | 0.03 | 0.18 | 4.06 | 12.10 | 43.02 |
Affimed NV Corporate Management
| Uwe Reusch | Head Culture | Profile | |
| Denise Mueller | Chief Board | Profile | |
| Arndt MD | Chief Board | Profile | |
| Angus Smith | CFO Board | Profile | |
| Michael Wolf | Head Administration | Profile | |
| Andreas MD | Chief Board | Profile | |
| Mary Sandin | Vice Communications | Profile |